November 21, 2008
U. of Kansas Sues NIH to Gain Credit for Patents Used in Anticancer Drug
The University of Kansas wants recognition—and a piece of the action—for the years of work it says two of its researchers contributed to developing an important and lucrative anticancer drug.
Through its patenting arm, the university has taken the unusual step of suing the National Institutes of Health to force the agency to add the two Kansas researchers as inventors on two key patents used to make the blockbuster drug known as Velcade, which is used in treating multiple
This is an article for subscribers only. You may access this article by purchasing a:
Digital or Print Subscription
Web Pass
Already have an account? Log In Now.
-
Notes From Academe
-
The Chronicle Review
-
Administration
